Ultragenyx Pharmaceutical Inc. Insider Trading for May 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ultragenyx Pharmaceutical Inc. for May 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27 2020 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | SVP, Controller and ... | Sell | S | 74.93 | 260 | 19,482 | 18,331 | 18.6 K to 18.3 K (-1.40 %) |
| May 27 2020 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | SVP, Controller and ... | Payment of Exercise | F | 73.81 | 433 | 31,960 | 18,591 | 19 K to 18.6 K (-2.28 %) |
| May 22 2020 | RARE | Ultragenyx Pharmac ... | Ultragenyx Pharmaceutical Inc. | Director | Option Exercise | M | 16.00 | 600,000 | 9,600,000 | 0 | |
| May 22 2020 | RARE | Ultragenyx Pharmac ... | Ultragenyx Pharmaceutical Inc. | Director | Buy | M | 16.00 | 600,000 | 9,600,000 | 3,000,000 | 2.4 M to 3 M (+25.00 %) |
| May 20 2020 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | M | 40.37 | 7,500 | 302,775 | 0 | |
| May 20 2020 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Sell | S | 74.65 | 7,500 | 559,875 | 47,924 | 55.4 K to 47.9 K (-13.53 %) |
| May 20 2020 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Buy | M | 40.37 | 7,500 | 302,775 | 55,424 | 47.9 K to 55.4 K (+15.65 %) |
| May 20 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Option Exercise | M | 70.57 | 3,907 | 275,717 | 500 | |
| May 20 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Option Exercise | M | 48.43 | 3,221 | 155,993 | 31,779 | |
| May 20 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Option Exercise | M | 70.57 | 19,593 | 1,382,678 | 4,407 | |
| May 20 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Sell | S | 73.32 | 3,907 | 286,461 | 101,556 | 105.5 K to 101.6 K (-3.70 %) |
| May 20 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Buy | M | 70.57 | 3,907 | 275,717 | 104,851 | 100.9 K to 104.9 K (+3.87 %) |
| May 20 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Sell | S | 73.32 | 3,221 | 236,164 | 100,944 | 104.2 K to 100.9 K (-3.09 %) |
| May 20 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Buy | M | 48.43 | 3,221 | 155,993 | 104,165 | 100.9 K to 104.2 K (+3.19 %) |
| May 20 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Sell | S | 73.29 | 2,392 | 175,310 | 100,944 | 103.3 K to 100.9 K (-2.31 %) |
| May 20 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Sell | S | 73.34 | 19,593 | 1,436,951 | 103,336 | 122.9 K to 103.3 K (-15.94 %) |
| May 20 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Buy | M | 70.57 | 19,593 | 1,382,678 | 122,929 | 103.3 K to 122.9 K (+18.96 %) |
| May 19 2020 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | SVP, Controller and ... | Option Exercise | M | 21.00 | 1,500 | 31,500 | 15,500 | |
| May 19 2020 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | SVP, Controller and ... | Sell | S | 71.00 | 1,500 | 106,500 | 19,024 | 20.5 K to 19 K (-7.31 %) |
| May 19 2020 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | SVP, Controller and ... | Buy | M | 21.00 | 1,500 | 31,500 | 20,219 | 18.7 K to 20.2 K (+8.01 %) |
| May 19 2020 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | SVP, Controller and ... | Sell | S | 71.00 | 961 | 68,231 | 18,719 | 19.7 K to 18.7 K (-4.88 %) |
| May 19 2020 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Sell | S | 75.00 | 1,875 | 140,625 | 11,000 | 12.9 K to 11 K (-14.56 %) |
| May 19 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 74.72 | 2,722 | 203,374 | 27,312 | 30 K to 27.3 K (-9.06 %) |
| May 08 2020 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 66.26 | 248 | 16,432 | 34,979 | 35.2 K to 35 K (-0.70 %) |
| May 08 2020 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | SVP, Controller and ... | Payment of Exercise | F | 66.26 | 138 | 9,144 | 19,680 | 19.8 K to 19.7 K (-0.70 %) |
| May 08 2020 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Payment of Exercise | F | 66.26 | 852 | 56,454 | 652,797 | 653.6 K to 652.8 K (-0.13 %) |
| May 08 2020 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & EVP | Payment of Exercise | F | 66.26 | 248 | 16,432 | 101,675 | 101.9 K to 101.7 K (-0.24 %) |
| May 08 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Payment of Exercise | F | 66.26 | 248 | 16,432 | 29,904 | 30.2 K to 29.9 K (-0.82 %) |
| May 08 2020 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Payment of Exercise | F | 66.26 | 248 | 16,432 | 48,991 | 49.2 K to 49 K (-0.50 %) |
| May 08 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Payment of Exercise | F | 66.26 | 248 | 16,432 | 103,336 | 103.6 K to 103.3 K (-0.24 %) |
| May 08 2020 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Payment of Exercise | F | 66.26 | 249 | 16,499 | 36,051 | 36.3 K to 36.1 K (-0.69 %) |
| May 08 2020 | RARE | Ultragenyx Pharmac ... | Harris Erik | EVP & Chief Commerc ... | Payment of Exercise | F | 66.26 | 209 | 13,848 | 24,153 | 24.4 K to 24.2 K (-0.86 %) |